相似文献
1
CAF-Targeting Antibody-Drug Conjugates (ADCs) in Solid Cancers.
Cancers (Basel). 2025 May 14;17(10):1654. doi: 10.3390/cancers17101654.
2
Cancer-Associated Fibroblasts in Conversation with Tumor Cells in Endometrial Cancers: A Partner in Crime.
Int J Mol Sci. 2021 Aug 24;22(17):9121. doi: 10.3390/ijms22179121.
3
A CAF-Based Two-Cell Hybrid Co-Culture Model to Test Drug Resistance in Endometrial Cancers.
Biomedicines. 2023 Apr 29;11(5):1326. doi: 10.3390/biomedicines11051326.
4
Targeting FAK improves the tumor uptake of antibody-drug conjugates to strengthen the anti-cancer responses.
iScience. 2024 Dec 6;28(3):111536. doi: 10.1016/j.isci.2024.111536. eCollection 2025 Mar 21.
5
Broadening Drug Design and Targets to Tumor Microenvironment? Cancer-Associated Fibroblast Marker Expression in Cancers and Relevance for Survival Outcomes.
OMICS. 2020 Jun;24(6):340-351. doi: 10.1089/omi.2020.0042.
6
Bête Noire of Chemotherapy and Targeted Therapy: CAF-Mediated Resistance.
Cancers (Basel). 2022 Mar 16;14(6):1519. doi: 10.3390/cancers14061519.
7
Cancer-associated fibroblasts in intrahepatic cholangiocarcinoma progression and therapeutic resistance.
Adv Cancer Res. 2022;156:201-226. doi: 10.1016/bs.acr.2022.01.009. Epub 2022 Feb 24.
8
Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
Mol Cancer. 2021 Oct 11;20(1):131. doi: 10.1186/s12943-021-01428-1.
9
Mesothelioma-associated fibroblasts enhance proliferation and migration of pleural mesothelioma cells via c-Met/PI3K and WNT signaling but do not protect against cisplatin.
J Exp Clin Cancer Res. 2023 Jan 23;42(1):27. doi: 10.1186/s13046-022-02582-0.
10
Metabolic and Immunological Implications of MMECAF-Mediated Hypoxia Signaling in Pancreatic Cancer Progression: Therapeutic Insights and Translational Opportunities.
Biol Proced Online. 2024 Sep 28;26(1):29. doi: 10.1186/s12575-024-00254-1.
本文引用的文献
1
Targeting FAK improves the tumor uptake of antibody-drug conjugates to strengthen the anti-cancer responses.
iScience. 2024 Dec 6;28(3):111536. doi: 10.1016/j.isci.2024.111536. eCollection 2025 Mar 21.
2
FGFR‑related phenotypic and functional profile of CAFs in prognostication of breast cancer (Review).
Int J Oncol. 2024 Oct;65(4). doi: 10.3892/ijo.2024.5682. Epub 2024 Sep 2.
3
Mechanistic Characterization of Cancer-associated Fibroblast Depletion via an Antibody-Drug Conjugate Targeting Fibroblast Activation Protein.
Cancer Res Commun. 2024 Jun 12;4(6):1481-1494. doi: 10.1158/2767-9764.CRC-24-0248.
4
Cancer-associated fibroblast classification in single-cell and spatial proteomics data.
Nat Commun. 2023 Jul 18;14(1):4294. doi: 10.1038/s41467-023-39762-1.
5
Integrated single-cell and bulk RNA sequencing analysis identifies a cancer-associated fibroblast-related gene signature for predicting survival and therapy in gastric cancer.
BMC Cancer. 2023 Jan 31;23(1):108. doi: 10.1186/s12885-022-10332-w.
6
The Cancer-Associated Fibroblasts-Related Gene COMP Is a Novel Predictor for Prognosis and Immunotherapy Efficacy and Is Correlated with M2 Macrophage Infiltration in Colon Cancer.
Biomolecules. 2022 Dec 28;13(1):62. doi: 10.3390/biom13010062.
7
uPARAP/Endo180: a multifaceted protein of mesenchymal cells.
Cell Mol Life Sci. 2022 Apr 22;79(5):255. doi: 10.1007/s00018-022-04249-7.
8
Fibroblast Activation Protein-α as a Target in the Bench-to-Bedside Diagnosis and Treatment of Tumors: A Narrative Review.
Front Oncol. 2021 Aug 19;11:648187. doi: 10.3389/fonc.2021.648187. eCollection 2021.
9
A phase 1 study of LY3076226, a fibroblast growth factor receptor 3 (FGFR3) antibody-drug conjugate, in patients with advanced or metastatic cancer.
Invest New Drugs. 2021 Dec;39(6):1613-1623. doi: 10.1007/s10637-021-01146-x. Epub 2021 Jul 15.
10
Impairment of a distinct cancer-associated fibroblast population limits tumour growth and metastasis.
Nat Commun. 2021 Jun 10;12(1):3516. doi: 10.1038/s41467-021-23583-1.
Zotero 插件